Articles on Actonel Once-a-Week (risedronate) from NPS RADARArticles on Actonel Once-a-Week (risedronate) from NPS RADAR

Title Content Type Date Description
Risedronate (Actonel and Actonel Once-a-Week) for corticosteroid-induced osteoporosis Professional publication - NPS RADAR - Brief item 2009-02-10 00:00:00 The PBS listing for risedronate (Actonel and Actonel Once-a-Week) and risedronate with calcium (Actonel Combi) has been extended to people with corticosteroid-induced osteoporosis (CIO) who are on long-term high-dose corticosteroid therapy.
Risedronate sodium (Actonel) and risedronate sodium with calcium carbonate (Actonel Combi) listing for osteoporosis in patients at high risk of fracture Professional publication - NPS RADAR - Brief item 2007-08-01 00:00:00 The PBS restriction for risedronate was extended o allow the treatment of osteoporosis among patients aged 70 years or older with low bone mineral density scores but without an existing minimal trauma fracture.

NPS RADAR: independent, evidence-based assessment of new drugs, new PBS listings and the latest research for doctors, pharmacists and other health professionals.

RSS FeedRSS feed

Date published: 2009-10-30 00:00:00

Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.

References to brands should not be taken as an endorsement by NPS.